Kyverna Therapeutics (KYTX) Other Working Capital Changes (2023 - 2026)
Kyverna Therapeutics posted quarterly Other Working Capital Changes of -$503000.0 for Q1 2026, down 1125.07% year-on-year from $49070.0 in Q1 2025, and up 40.4% on a QoQ basis from -$844000.0 in Q4 2025.
Kyverna Therapeutics (KYTX) has 4 years of Other Working Capital Changes data on file, last reported at -$503000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 1125.07% year-over-year to -$503000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.1 million (down 8367.78% YoY), and the FY2025 full-year result was $405195.0, up 8339.8% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$503000.0, up from -$844000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $357375.0 in Q3 2025 and bottomed at -$2.7 million in Q4 2024.
- The 4-year median for Other Working Capital Changes is -$434000.0 (2023), against an average of -$434633.9.
- The widest annual swing landed in 2025, when Other Working Capital Changes jumped 8765.67%; it then slumped 1125.07% in 2026.
- A 4-year view of Other Working Capital Changes shows it stood at -$463000.0 in 2023, then tumbled by 482.07% to -$2.7 million in 2024, then jumped by 68.68% to -$844000.0 in 2025, then surged by 40.4% to -$503000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$503000.0 (Q1 2026), -$844000.0 (Q4 2025), and $357375.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kyverna Therapeutics | 497.98 Mn | 265.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -503,000.00 |
| Mar 31, 2026 | -503,000.00 |
| Dec 31, 2025 | -844,000.00 |
| Dec 31, 2025 | -844,000.00 |
| Sep 30, 2025 | 357,375.00 |
| Sep 30, 2025 | 357,375.00 |
| Jun 30, 2025 | 195,283.00 |
| Jun 30, 2025 | 195,283.00 |
| Mar 31, 2025 | 49,070.00 |
| Mar 31, 2025 | 49,070.00 |
| Dec 31, 2024 | -2.70 Mn |
| Dec 31, 2024 | -2.70 Mn |
| Sep 30, 2024 | 4,031.00 |
| Sep 30, 2024 | 4,031.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -520,000.00 |
| Mar 31, 2024 | -520,000.00 |
| Dec 31, 2023 | -463,000.00 |
| Dec 31, 2023 | -463,000.00 |
| Sep 30, 2023 | -441,000.00 |
| Sep 30, 2023 | -441,000.00 |
| Jun 30, 2023 | -434,000.00 |
| Jun 30, 2023 | -434,000.00 |
| Mar 31, 2023 | -341,000.00 |
| Mar 31, 2023 | -341,000.00 |